Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 14 on this page, newest registry updates first. Search checked 2026-11-08 21:15 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

DILIPO (DILutIonal HyPOnatremia)

ClinicalTrials.gov · NCT00274326 · Registry updated: 2008-09-15

Condition / research focus: Congestive Heart Failure
Sponsor: Sanofi
Countries with listed sites: Argentina · Australia · Belgium · Canada · Chile · Denmark · Greece · Hungary · Israel · Poland · Portugal · Romania · South Africa · Sweden · United States
Registry dates and results: Start: 2005-05. Completion: 2007-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

SR121463B (drug)

Where the study takes place — 15 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Sanofi-Aventis Administrative Office
Bridgewater, New Jersey, United States
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Buenos Aires, Argentina
Site recruitment: Not reported
sanofi-aventis Australia & New Zealand administrative office
Macquarie Park, New South Wales, Australia
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Diegem, Belgium
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Laval, Canada
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Santiago, Chile
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Hørsholm, Denmark
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Athens, Greece
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Budapest, Hungary
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Netanya, Israel
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Warsaw, Poland
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Porto Salvo, Portugal
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Bucharest, Romania
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Midrand, South Africa
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Bromma, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

ClinicalTrials.gov · NCT00032734 · Registry updated: 2008-06-17

Condition / research focus: Syndrome of Inappropriate ADH (SIADH) Secretion; Hyponatremia
Sponsor: Sanofi
Countries with listed sites: Belgium · France · Germany · Hungary
Registry dates and results: Start: 2001-06. Completion: 2003-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

satavaptan (SR121463B) (drug)

Where the study takes place — 4 listed sites

Sanofi-aventis Administrative Office
Diegem, Belgium
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Paris, France
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Berlin, Germany
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Budapest, Hungary
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).

ClinicalTrials.gov · NCT00032747 · Registry updated: 2008-06-17

Condition / research focus: Chronic Heart Failure
Sponsor: Sanofi
Countries with listed sites: Canada · United Kingdom · United States
Registry dates and results: Start: 2001-08. Completion: 2003-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin V2 Receptor Antagonist (drug)

Where the study takes place — 9 listed sites

University of Alabama at Birmingham
Birmingham, Alabama, United States
Site recruitment: Not reported
Emory University
Atlanta, Georgia, United States
Site recruitment: Not reported
University of Iowa Hospital and Clinics
Iowa City, Iowa, United States
Site recruitment: Not reported
University of Maryland School of Medicine
Baltimore, Maryland, United States
Site recruitment: Not reported
Brian LGH Heart Institute
Lincoln, Nebraska, United States
Site recruitment: Not reported
The Lindner Clinical Trial Center
Cincinnati, Ohio, United States
Site recruitment: Not reported
MUSC/Division Cardiology
Charleston, South Carolina, United States
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Laval, Canada
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Guildford Surrey, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableSuspendedOBSERVATIONAL

Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea

ClinicalTrials.gov · NCT00438412 · Registry updated: 2008-04-22

Condition / research focus: Obstructive Sleep Apnea
Sponsor: Regional Hospital Holstebro
Countries with listed sites: Denmark
Registry dates and results: Start: 2006-10. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Department of Medical Research, Holstebro Hospital
Holstebro, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Noradrenalin vs Terlipressin in Hepatorenal Syndrome

ClinicalTrials.gov · NCT00370253 · Registry updated: 2008-04-11

Condition / research focus: Hepatorenal Syndrome
Sponsor: University of Turin, Italy
Countries with listed sites: Italy
Registry dates and results: Start: 2006-09. Completion: 2007-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)
Noradrenalin (drug)

Where the study takes place — 1 listed sites

San Giovanni Battista Hospital
Turin, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Continuous Infusion of Terlipressin in Septic Shock

ClinicalTrials.gov · NCT00481572 · Registry updated: 2008-02-29

Condition / research focus: Septic Shock
Sponsor: University of Roma La Sapienza
Countries with listed sites: Italy
Registry dates and results: Start: 2007-01. Completion: 2007-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)
Vasopressin (drug)
Norepinephrine (drug)

Where the study takes place — 1 listed sites

Department of Anesthesiology and Intensive care of the University of Rome "La Sapienza"
Rome, Viale Del Policlinico 155, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3TerminatedINTERVENTIONAL

Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

ClinicalTrials.gov · NCT00592566 · Registry updated: 2008-01-14

Condition / research focus: Leptospirosis
Sponsor: Mahidol University
Countries with listed sites: Thailand
Registry dates and results: Start: 2003-07. Completion: 2006-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dexamethasone, desmopressin (drug) — also listed as: Minirin

Where the study takes place — 1 listed sites

Loei Hospital
Mueng, Changwat Loei, Thailand
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed

ClinicalTrials.gov · NCT00534677 · Registry updated: 2007-12-05

Condition / research focus: Portal Hypertension; Cirrhosis; Hematemesis; Melena
Sponsor: Aga Khan University
Countries with listed sites: Pakistan
Registry dates and results: Start: 2004-05. Completion: 2005-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: Novapresin
Octreotide (drug) — also listed as: sandostatin

Where the study takes place — 1 listed sites

The Aga Khan University Hospital
Karachi, Sindh, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4SuspendedINTERVENTIONAL

Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin

ClinicalTrials.gov · NCT00287664 · Registry updated: 2007-04-11

Condition / research focus: Cirrhosis; Hepatorenal Syndrome
Sponsor: Hospital Clinic of Barcelona
Countries with listed sites: Spain
Registry dates and results: Start: 2002-02. Completion: 2006-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

terlipressin (drug)

Where the study takes place — 1 listed sites

Hospital Clinic
Barcelona, Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Treatment and Management of Women With Bleeding Disorders

ClinicalTrials.gov · NCT00111215 · Registry updated: 2007-03-13

Condition / research focus: Menorrhagia; Blood Coagulation Disorders; Blood Platelet Disorders; Von Willebrand Disease; Hematologic Disease
Sponsor: Centers for Disease Control and Prevention
Countries with listed sites: United States
Registry dates and results: Start: 2001-01. Completion: 2006-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic Acid (drug)
Desmopressin Acetate (drug)

Where the study takes place — 6 listed sites

Emory University School of Medicine
Atlanta, Georgia, United States
Site recruitment: Not reported
Michigan State University
East Lansing, Michigan, United States
Site recruitment: Not reported
The Mayo Clinic
Rochester, Minnesota, United States
Site recruitment: Not reported
UMDNJ Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
Site recruitment: Not reported
Mary M. Gooley Hemophilia Center
Rochester, New York, United States
Site recruitment: Not reported
Duke University Medical Center
Durham, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Comparison of Vasopressin and Other Pressors in Septic Shock

ClinicalTrials.gov · NCT00269685 · Registry updated: 2006-05-29

Condition / research focus: Shock, Septic
Sponsor: Université de Sherbrooke
Countries with listed sites: No country reported
Registry dates and results: Start: 2000-07. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

vasopressin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites

ClinicalTrials.gov · NCT00115947 · Registry updated: 2006-03-09

Condition / research focus: Cirrhosis; Ascites
Sponsor: Hvidovre University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2004-12. Completion: 2006-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)

Where the study takes place — 1 listed sites

Hvidovre Hospital
Copenhagen, Hvidovre, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Study of Novel Types of Familial Diabetes Insipidus

ClinicalTrials.gov · NCT00004364 · Registry updated: 2006-02-22

Condition / research focus: Diabetes Insipidus
Sponsor: National Center for Research Resources (NCRR)
Countries with listed sites: No country reported
Registry dates and results: Start: 1995-12. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus

ClinicalTrials.gov · NCT00004363 · Registry updated: 2005-06-24

Condition / research focus: Diabetes Insipidus; Diabetes Insipidus, Neurohypophyseal
Sponsor: National Center for Research Resources (NCRR)
Countries with listed sites: United States
Registry dates and results: Start: 1995-12. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

chlorpropamide (drug)
desmopressin (drug)

Where the study takes place — 1 listed sites

Northwestern University Medical School
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 14 on this page, newest registry updates first. Search checked 2026-11-08 21:15 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3CompletedINTERVENTIONAL

DILIPO (DILutIonal HyPOnatremia)

ClinicalTrials.gov · NCT00274326 · Registry updated: 2008-09-15

Condition / research focus: Congestive Heart Failure
Sponsor: Sanofi
Countries with listed sites: Argentina · Australia · Belgium · Canada · Chile · Denmark · Greece · Hungary · Israel · Poland · Portugal · Romania · South Africa · Sweden · United States
Registry dates and results: Start: 2005-05. Completion: 2007-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

SR121463B (drug)

Where the study takes place — 15 listed sites

Sanofi-Aventis Administrative Office
Bridgewater, New Jersey, United States
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Buenos Aires, Argentina
Site recruitment: Not reported
sanofi-aventis Australia & New Zealand administrative office
Macquarie Park, New South Wales, Australia
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Diegem, Belgium
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Laval, Canada
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Santiago, Chile
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Hørsholm, Denmark
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Athens, Greece
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Budapest, Hungary
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Netanya, Israel
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Warsaw, Poland
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Porto Salvo, Portugal
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Bucharest, Romania
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Midrand, South Africa
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Bromma, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

ClinicalTrials.gov · NCT00032734 · Registry updated: 2008-06-17

Condition / research focus: Syndrome of Inappropriate ADH (SIADH) Secretion; Hyponatremia
Sponsor: Sanofi
Countries with listed sites: Belgium · France · Germany · Hungary
Registry dates and results: Start: 2001-06. Completion: 2003-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

satavaptan (SR121463B) (drug)

Where the study takes place — 4 listed sites

Sanofi-aventis Administrative Office
Diegem, Belgium
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Paris, France
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Berlin, Germany
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Budapest, Hungary
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).

ClinicalTrials.gov · NCT00032747 · Registry updated: 2008-06-17

Condition / research focus: Chronic Heart Failure
Sponsor: Sanofi
Countries with listed sites: Canada · United Kingdom · United States
Registry dates and results: Start: 2001-08. Completion: 2003-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin V2 Receptor Antagonist (drug)

Where the study takes place — 9 listed sites

University of Alabama at Birmingham
Birmingham, Alabama, United States
Site recruitment: Not reported
Emory University
Atlanta, Georgia, United States
Site recruitment: Not reported
University of Iowa Hospital and Clinics
Iowa City, Iowa, United States
Site recruitment: Not reported
University of Maryland School of Medicine
Baltimore, Maryland, United States
Site recruitment: Not reported
Brian LGH Heart Institute
Lincoln, Nebraska, United States
Site recruitment: Not reported
The Lindner Clinical Trial Center
Cincinnati, Ohio, United States
Site recruitment: Not reported
MUSC/Division Cardiology
Charleston, South Carolina, United States
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Laval, Canada
Site recruitment: Not reported
Sanofi-aventis Administrative Office
Guildford Surrey, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableSuspendedOBSERVATIONAL

Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea

ClinicalTrials.gov · NCT00438412 · Registry updated: 2008-04-22

Condition / research focus: Obstructive Sleep Apnea
Sponsor: Regional Hospital Holstebro
Countries with listed sites: Denmark
Registry dates and results: Start: 2006-10. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Department of Medical Research, Holstebro Hospital
Holstebro, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Noradrenalin vs Terlipressin in Hepatorenal Syndrome

ClinicalTrials.gov · NCT00370253 · Registry updated: 2008-04-11

Condition / research focus: Hepatorenal Syndrome
Sponsor: University of Turin, Italy
Countries with listed sites: Italy
Registry dates and results: Start: 2006-09. Completion: 2007-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)
Noradrenalin (drug)

Where the study takes place — 1 listed sites

San Giovanni Battista Hospital
Turin, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Continuous Infusion of Terlipressin in Septic Shock

ClinicalTrials.gov · NCT00481572 · Registry updated: 2008-02-29

Condition / research focus: Septic Shock
Sponsor: University of Roma La Sapienza
Countries with listed sites: Italy
Registry dates and results: Start: 2007-01. Completion: 2007-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)
Vasopressin (drug)
Norepinephrine (drug)

Where the study takes place — 1 listed sites

Department of Anesthesiology and Intensive care of the University of Rome "La Sapienza"
Rome, Viale Del Policlinico 155, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3TerminatedINTERVENTIONAL

Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

ClinicalTrials.gov · NCT00592566 · Registry updated: 2008-01-14

Condition / research focus: Leptospirosis
Sponsor: Mahidol University
Countries with listed sites: Thailand
Registry dates and results: Start: 2003-07. Completion: 2006-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dexamethasone, desmopressin (drug) — also listed as: Minirin

Where the study takes place — 1 listed sites

Loei Hospital
Mueng, Changwat Loei, Thailand
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed

ClinicalTrials.gov · NCT00534677 · Registry updated: 2007-12-05

Condition / research focus: Portal Hypertension; Cirrhosis; Hematemesis; Melena
Sponsor: Aga Khan University
Countries with listed sites: Pakistan
Registry dates and results: Start: 2004-05. Completion: 2005-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug) — also listed as: Novapresin
Octreotide (drug) — also listed as: sandostatin

Where the study takes place — 1 listed sites

The Aga Khan University Hospital
Karachi, Sindh, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4SuspendedINTERVENTIONAL

Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin

ClinicalTrials.gov · NCT00287664 · Registry updated: 2007-04-11

Condition / research focus: Cirrhosis; Hepatorenal Syndrome
Sponsor: Hospital Clinic of Barcelona
Countries with listed sites: Spain
Registry dates and results: Start: 2002-02. Completion: 2006-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

terlipressin (drug)

Where the study takes place — 1 listed sites

Hospital Clinic
Barcelona, Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Treatment and Management of Women With Bleeding Disorders

ClinicalTrials.gov · NCT00111215 · Registry updated: 2007-03-13

Condition / research focus: Menorrhagia; Blood Coagulation Disorders; Blood Platelet Disorders; Von Willebrand Disease; Hematologic Disease
Sponsor: Centers for Disease Control and Prevention
Countries with listed sites: United States
Registry dates and results: Start: 2001-01. Completion: 2006-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tranexamic Acid (drug)
Desmopressin Acetate (drug)

Where the study takes place — 6 listed sites

Emory University School of Medicine
Atlanta, Georgia, United States
Site recruitment: Not reported
Michigan State University
East Lansing, Michigan, United States
Site recruitment: Not reported
The Mayo Clinic
Rochester, Minnesota, United States
Site recruitment: Not reported
UMDNJ Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
Site recruitment: Not reported
Mary M. Gooley Hemophilia Center
Rochester, New York, United States
Site recruitment: Not reported
Duke University Medical Center
Durham, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Comparison of Vasopressin and Other Pressors in Septic Shock

ClinicalTrials.gov · NCT00269685 · Registry updated: 2006-05-29

Condition / research focus: Shock, Septic
Sponsor: Université de Sherbrooke
Countries with listed sites: No country reported
Registry dates and results: Start: 2000-07. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

vasopressin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites

ClinicalTrials.gov · NCT00115947 · Registry updated: 2006-03-09

Condition / research focus: Cirrhosis; Ascites
Sponsor: Hvidovre University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2004-12. Completion: 2006-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin (drug)

Where the study takes place — 1 listed sites

Hvidovre Hospital
Copenhagen, Hvidovre, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Study of Novel Types of Familial Diabetes Insipidus

ClinicalTrials.gov · NCT00004364 · Registry updated: 2006-02-22

Condition / research focus: Diabetes Insipidus
Sponsor: National Center for Research Resources (NCRR)
Countries with listed sites: No country reported
Registry dates and results: Start: 1995-12. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

desmopressin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus

ClinicalTrials.gov · NCT00004363 · Registry updated: 2005-06-24

Condition / research focus: Diabetes Insipidus; Diabetes Insipidus, Neurohypophyseal
Sponsor: National Center for Research Resources (NCRR)
Countries with listed sites: United States
Registry dates and results: Start: 1995-12. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

chlorpropamide (drug)
desmopressin (drug)

Where the study takes place — 1 listed sites

Northwestern University Medical School
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →